A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Tissue matrix scaffold is an advanced tissue-mimicry 3D culture system for biomedical research and drug screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer and stromal cells are cultured in a compartmental fashion that induces the expression of intracellular and extracellular biomarkers of breast cancer cells, thus con fi rming correct tumor growth and proliferation.”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This TMS therefore mimics the structure of the mammary tissue while providing a simple-to-use tool for screening speci fi c tumor biomarkers [35].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“A tissue matrix scaffold (TMS) using native ECM has been developed to overcome cell culture methods that do not mimic the biophysical/biochemical properties of the ECM [35].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“This in vitro model consists of a multilayered tissue culture platform prepared from decellularized mouse mammary tissue.”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels for Tissue Engineering
Lee, K. Y., & Mooney, D. J. (2001) · Chemical Reviews · doi:10.1021/cr000108x · Cited by 5,277
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“1D, bottom right), where rich adipose and less connective tissues are present (42).”
BackgroundPrinting three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
Basement membrane complexes with biological activity
Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., & Martin, G. R. (1986) · Biochemistry · doi:10.1021/bi00350a005 · Cited by 1,502 · cited 1×
“Because the tumor and normal tissue ECM are different, and the ECMcomponents are critical for the expression of specific cell surface receptors (14), the tumor-derived laminin- and collagen IV–rich hydrogelmay not be appropriate for certain cell signaling andmolecular mechanistic studies that involve culturing normal…”
BackgroundCarcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144
Research works printed but not linked: 1
- M. V. Patrone, J. L. Hubbs, J. E. Bailey, L. B. Marks, How long have I had my cancer, doctor? Estimating tumor age via Collins’ law. Oncology (Williston Park) 25, 38–43 (2011).
Cited by
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440
“Porous scaffolds are widely used in the bioengineering sector, and have gained prominence in 3D cell culture implementation [63,72,79].”
Background3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
“This TMS therefore mimics the structure of the mammary tissue while providing a simple-to-use tool for screening specific tumor biomarkers [35].”
MethodTumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
“Based on these considerations, Rijal et al. developed a native ECM based tissue matrix scaffold (TMS) [201].”
BackgroundInfluentialBarbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
“Interestingly, Rijal and Li evaluated the impact of different scaffolds (decellularized mouse breast ECMs, Collagen, Laminin-rich ECM, and PLGA) on the sensitivity of Estrogen-Receptor-positive breast cancer cell lines (T47D and BT474) to tamoxifen (4hydroxytamoxifen) and paclitaxel [92].”
Background3D Bioprinted in vitro metastatic models via reconstruction of tumor microenvironments
Meng, F., Meyer, C. M., Joung, D., Vallera, D. A., McAlpine, M. C., & Panoskaltsis‐Mortari, A. (2019) · Advanced Materials · doi:10.1002/adma.201806899 · Cited by 262
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
“Interestingly, a pro-tumoral phenotype of T47D and BT474 breast cancer cells tumoroids was obtained when anti-cancer drug-screening assays were performed in dECMs in comparison with other tested scaffolds (Collagen, Laminin rich ECM, PLGA) [125].”
BackgroundResultInfluential3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels
Mollica, P. A., Booth-Creech, E. N., Reid, J. A., Zamponi, M., Sullivan, S. M., Palmer, X.-L., Sachs, P. C., & Bruno, R. D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.017 · Cited by 206
Decellularized Extracellular Matrix for Bioengineering Physiomimetic 3D in Vitro Tumor Models
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.04.006 · Cited by 153
Cell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kitaeva, K. V., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00322 · Cited by 142
3D bioprinted cancer models: from basic biology to drug development
Neufeld, L., Yeini, E., Pozzi, S., & Satchi‐Fainaro, R. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00514-w · Cited by 155
Applications of Microfluidics and Organ-on-a-Chip in Cancer Research
Regmi, S., Poudel, C., Adhikari, R., & Luo, K. Q. (2022) · Biosensors · doi:10.3390/bios12070459 · Cited by 143
Engineering Breast Cancer Microenvironments and 3D Bioprinting
Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00066 · Cited by 109
“Additionally, drug resistance was decreased on TMS when compared to the other 3D scaffolds (Rijal and Li, 2017).”
BackgroundDecellularised scaffolds: just a framework? Current knowledge and future directions
García-Gareta, E., Abduldaiem, Y., Sawadkar, P., Kyriakidis, C., Lali, F., & Greco, K. V. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420942903 · Cited by 109
Strategies for improving the 3D printability of decellularized extracellular matrix bioink
Zhang, H., Wang, Y., Zheng, Z., Wei, X., Chen, L., Wu, Y., Huang, W., & Yang, L. (2023) · Theranostics · doi:10.7150/thno.81785 · Cited by 114
“dECM preserves not only the biomechanical properties of the initial tumor but also the composition and architecture of the ECM, generating a perfect tumor microenvironment [152].”
BackgroundOn-chip integrated optical stretching and electrorotation enabling single-cell biophysical analysis
Huang, L. J., Liang, F., Feng, Y., Zhao, P., & Wang, W. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-0162-2 · Cited by 92
Nie, J., Gao, Q., Xie, C., Lv, S., Qiu, J., Liu, Y., Guo, M. A., Guo, R., Fu, J., & He, Y. (2019) · Materials Horizons · doi:10.1039/c9mh01283d · Cited by 91
Blanco‐Fernandez, B., Rey-Viñolas, S., Bağcı, G., Rubí-Sans, G., Otero, J., Navajas, D., Pérez‐Amodio, S., & Engel, E. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c00920 · Cited by 88
“15,39 The similarities between the human and pig genome, availability, and large size of the pig mammary glands have prompted the use of this type of breast tissue for the preparation of a biomimetic ECM bioink.”
Bioinspired Helical Micromotors as Dynamic Cell Microcarriers
Yu, Y., Guo, J., Wang, Y., Shao, C., Wang, Y., & Zhao, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01264 · Cited by 81
Rijal, G., & Li, W. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0114-7 · Cited by 86
Self-citation3D culture technologies of cancer stem cells: promising ex vivo tumor models
Zhang, C., Yang, Z., Dong, D.-L., Jang, T., Knowles, J. C., Kim, H., Jin, G., & Xuan, Y. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420933407 · Cited by 85
Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective
Blidișel, A., Marcovici, I., Coricovac, D. E., Huţ, E. F., Dehelean, C. A., & Cretu, O. M. (2021) · Cancers · doi:10.3390/cancers13153651 · Cited by 83
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Rodrigues, D. B., Reis, R. L., & Pirraco, R. P. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00997-9 · Cited by 94
Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment
Zhuang, P., Chiang, Y., Fernanda, M. S., & He, M. L. (2024) · International Journal of Bioprinting · doi:10.18063/ijb.v7i4.444 · Cited by 80
“Substantial evidence has revealed that 3D culture is more physiologically relevant in comparison to planar culture[6,7].”
BackgroundLv, Y., Wang, H., Li, G., & Zhao, B. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.004 · Cited by 67
“these models contain several uncontrollable factors, such as hemodynamics, immune response and animal individual differences [15,16].”
BackgroundTyrosinase‐mediated hydrogel crosslinking for tissue engineering
Choi, S., Ahn, H., & Kim, S. (2021) · Journal of Applied Polymer Science · doi:10.1002/app.51887 · Cited by 68
Tissue engineering the cancer microenvironment—challenges and opportunities
Papalazarou, V., Salmerón‐Sánchez, M., & Machesky, L. M. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0466-8 · Cited by 66
Organotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening
Ferreira, L. P., Gaspar, V. M., Mendes, L., Duarte, I. F., & Mano, J. F. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120983 · Cited by 59
“Collagen and GAGs content is in accordance with other reports that employed a similar decellularization protocol [57,58].”
ResultA poly(ethylene glycol) three-dimensional bone marrow hydrogel
Jansen, L., Kim, H., Hall, C. L., McCarthy, T. P., Lee, M. J., & Peyton, S. R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121270 · Cited by 66
Song, H., Cai, G.-H., Liang, J., Ao, D.-S., Wang, H., & Yang, Z.-H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00646-x · Cited by 52
“The tumor locus was a spatial and temporal 3D cell microenvironment undergoing multifaceted tissue remodeling at extracellular, intercellular, and intracellular levels [3, 4].”
BackgroundSensi, F., D’Angelo, E., Piccoli, M., Pavan, P. G., Mastrotto, F., Caliceti, P., Biccari, A., Corallo, D., Urbani, L., Fassan, M., et al. (2020) · Cancers · doi:10.3390/cancers12030681 · Cited by 57
Faber, S. C., & McCullough, S. D. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0002 · Cited by 61
“Furthermore, the presence of ECM or scaffolding can influence variability across study systems, as organoids and spheroids have demonstrated differential morphology when cultured on rigid surfaces versus scaffolds.(37,38,146) Protocols are being developed to implement uniform sphere sizes, such as the defined size mic…”
BackgroundRyu, H., Park, Y., Luan, H., Dalgin, G., Jeffris, K., Yoon, H., Chung, T. S., Kim, J. U., Kwak, S. S., Lee, G., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100026 · Cited by 59
García‐Astrain, C., Henriksen‐Lacey, M., Lenzi, E., Renero‐Lecuna, C., Langer, J., Piñeiro, P., Molina-Martínez, B., Plou, J., de Aberasturi, D. J., & Liz‐Marzán, L. M. (2024) · ACS Nano · doi:10.1021/acsnano.4c00543 · Cited by 50
Rijal, G., Bathula, C. S., & Li, W. (2017) · International Journal of Biomaterials · doi:10.1155/2017/8074890 · Cited by 56
Self-citationSmart biomaterial platforms: Controlling and being controlled by cells
Narkar, A. R., Tong, Z., Soman, P., & Henderson, J. H. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121450 · Cited by 47
“Most of these studies involve a combination of experimental, theoretical, and modeling strategies to characterize the effect of cell mobility on ECM remodeling [57, 58].”
BackgroundPlou, J., Molina-Martínez, B., García‐Astrain, C., Langer, J., García, I., Ercilla, A., Perumal, G., Carracedo, A., & Liz‐Marzán, L. M. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c03070 · Cited by 44
“19 Even though these approaches have revealed new elements in cell biology, 20 the incorporated third dimension drastically hampered the e ffi cient capture of dynamic aspects, such as drug or nutrient transport, by optical methods.”
From tumour perfusion to drug delivery and clinical translation of in silico cancer models
Hadjicharalambous, M., Wijeratne, P. A., & Vavourakis, V. (2020) · Methods · doi:10.1016/j.ymeth.2020.02.010 · Cited by 47
“significant contributions have been reported with a strong potential for use in surgical and radio-therapeutic treatment planning [95], to interrogate tumour normalisation strategies [96], and to test anti-cancer agents on bioartificial tissues mimicking a patient’s own tissue or organ [97].”
BackgroundLeiva, M. C., Garré, E., Gustafsson, A., Svanström, A., Bogestål, Y. R., Håkansson, J., Ståhlberg, A., & Landberg, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30191 · Cited by 42
“…with previous reports, the results clearly indicated a higher drug resistance in cells cultured in PDSs in comparison to the 2D cultures, demonstrating that the growth of cells in a 3D conformation increases their robustness against chemotherapeutic drugs (Miyauchi et al., 2017; Rijal & Li, 2017).”
BackgroundResult3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy
Sharifi, M., Bai, Q., Babadaei, M. M. N., Chowdhury, F., Hassan, M., Taghizadeh, A., Derakhshankhah, H., Suliman, K., Hasan, A., & Falahati, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.026 · Cited by 42
Vascularised organoids: Recent advances and applications in cancer research
Zhou, R., Brislinger, D., Fuchs, J., Lyons, A., Langthaler, S., Hauser, C. A. E., & Baumgartner, C. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70258 · Cited by 41
Kim, J., Jang, J., & Cho, D. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.605819 · Cited by 44
“tissue ECM have also been reported (Rijal and Li, 2017; Tian et al., 2018).”
BackgroundTurtoi, M., Anghelache, M., Bucătariu, S., Deleanu, M., Voicu, G., Safciuc, F., Mânduțeanu, I., Fundueanu, G., Simionescu, M., & Călin, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.174 · Cited by 41
Schmid, R., Schmidt, S. K., Hazur, J., Detsch, R., Maurer, E., Boccaccini, A. R., Hauptstein, J., Teßmar, J., Blunk, T., Schrüfer, S., et al. (2020) · Cancers · doi:10.3390/cancers12082320 · Cited by 45
“Such 3D models would enable the tumor cells to adopt different phenotypes that mimic the in vivo situation appropriately [10].”
BackgroundRizzo, R., Onesto, V., Forciniti, S., Chandra, A., Prasad, S., Iuele, H., Colella, F., Gigli, G., & del Mercato, L. L. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114401 · Cited by 40
Distinct phenotypes of cancer cells on tissue matrix gel
Ruud, K. F., Hiscox, W. C., Yu, I., Chen, R. K., & Li, W. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01321-7 · Cited by 35
“Compared to TMG and Col I, Matrigel naturally carries certain ligands and growth factors native to mouse sarcoma tissues but has minimum collagen and other major ECM protein contents [37, 39], and therefore may maintain the dedifferentiation states of the cancer cells better than TMG and Col I, as reflected by the exp…”
BackgroundMethodInfluentialSelf-citationMajor, G. S., Ahn, M., Cho, W.-W., Santos, M., Wise, J., Phillips, E., Wise, S. G., Jang, J., Rnjak‐Kovacina, J., Woodfield, T. B. F., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101004 · Cited by 43
“These differences can likely be attributed to a disparity in donor tissue species and the use of a harsher decellularisation protocol which may have diminished more soluble proteoglycans [44].”
BackgroundResultInfluentialPark, Y., Luan, H., Kwon, K., Zhao, S., Franklin, D., Wang, H., Zhao, H., Bai, W., Kim, J. U., Lu, W., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201903181 · Cited by 34
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 36
Flipped Well-Plate Hanging-Drop Technique for Growing Three-Dimensional Tumors
Jeong, Y., Tin, A., & Irudayaraj, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.898699 · Cited by 36
“Wherein, the biological activities of the tumor cells, either selfaggregated or confined in the artificial matrix, could be passively affected by the physicochemical cues with respect to their surroundings, and vice versa (Rijal and Li, 2017).”
BackgroundKey aspects for conception and construction of co-culture models of tumor-stroma interactions
Mason, J. E., & Öhlund, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1150764 · Cited by 32
“An alternative method of solid scaffold generation is to take directly tissue or organs with an appropriate structure, remove the endemic cells and then re-seed with the cell type of interest (Crapo et al., 2011; He and Callanan, 2013; Rijal and Li, 2017).”
Methodde Dios-Figueroa, G. T., Aguilera-Márquez, J. D. R., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060602 · Cited by 35
“Scaffolds can simulate cell–ECM and cell– cell interactions; therefore, these systems can elucidate ECM and tight cell junctions that influence the cytotoxic effect of compounds and treatments [52,53].”
BackgroundCalvaruso, M., Militello, C., Minafra, L., Regina, V. L., Torrisi, F., Pucci, G., Cammarata, F. P., Bravatà, V., Forte, G. I., & Russo, G. I. (2021) · Life · doi:10.3390/life11111190 · Cited by 34
“Multicellular spheroids are currently used in basic research using scaffold-free or scaffold-dependent techniques [34,35] and represent a potent tool to mimic the in vivo microenvironment without resorting to animal models, used in many biological fields such as tumor modeling, tissue engineering, and drug testing [36…”
MethodStewart, D. C., Brisson, B. K., Dekky, B., Berger, A. C., Yen, W. K., Mauldin, E. A., Loebel, C., GILLETTE, D. M., Assenmacher, C., QUINCEY, C., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00690-y · Cited by 34
“Collagen is the most abundant protein in the ECM of breast tumors 16 .”
BackgroundHydrocolloids of Egg White and Gelatin as a Platform for Hydrogel-Based Tissue Engineering
Pele, K. G., Amaveda, H., Mora, M., Marcuello, C., Lostao, A., Alamán‐Díez, P., Peréz‐Huertas, S., Pérez, M. Á., García‐Aznar, J. M., & García‐Gareta, E. (2023) · Gels · doi:10.3390/gels9060505 · Cited by 33
Porcine Breast Extracellular Matrix Hydrogel for Spatial Tissue Culture
Rijal, G., Wang, J., Yu, I., Gang, D. R., Chen, R. K., & Li, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102912 · Cited by 28
“The ECM was lyophilized and assessed for decellularization efficiency using the removal of DNA content (<50 ng per milligram of dried ECM) and the maximal retention of collagen and glycosaminoglycan (GAG) within the ECM as parameter references as described previously [15].”
BackgroundMethodResultSelf-citationZhou, Y. X., Fan, Y., Chen, Z. X., Yue, Z., & Wallace, G. G. (2021) · Biofabrication · doi:10.1088/1758-5090/ac2ef8 · Cited by 31
“Cell-laden scaffolds that can mimic native tissue are also of great value for drug screening or other fundamental studies [3, 4].”
BackgroundTumor organoids in immunotherapy: from disease modeling to translational research
Si, Q., Tao, S., Wu, J., Ma, J., Li, Z. Y., Feng, X., Song, J., Kong, T., & Zhou, Z. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011733 · Cited by 31
“12 Emerging innovations, such as vascularized co-culture systems, 13 multiomics-driven TME profiling, 14 and bioengineered matrix scaffolds, 15 are anticipated to enhance organoid fidelity and throughput.”
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
Rabie, A. M. I., Ali, A. S. M., Al‐Zeer, M. A., Barhoum, A., El-hallouty, S. M., Shousha, W. G., Berg, J., Kurreck, J., & Khalil, A. S. G. (2022) · ACS Omega · doi:10.1021/acsomega.1c05646 · Cited by 24
Lee, J., Park, D., Seo, Y., Chung, J. J., Jung, Y., & Kim, S. H. (2020) · Advanced Materials · doi:10.1002/adma.202002096 · Cited by 24
Shinsato, Y., Doyle, A. D., Li, W., & Yamada, K. M. (2020) · Cancer Reports · doi:10.1002/cnr2.1257 · Cited by 23
“3D matrices used recently that employ physiological extracellular matrix molecules include collagen 3D matrices, cell-derived matrix (CDM), and tissue matrix gel (TMG).(16-20) Collagen 3D matrices based primarily on collagen I are used more frequently.”
Self-citationSeo, Y., Bang, S., Son, J., Kim, D., Jeong, Y., Kim, P., Yang, J.-H., Eom, J.-H., Choi, N., & Kim, H. N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.009 · Cited by 24
Organoids technology in cancer research: from basic applications to advanced ex vivo models
Varinelli, L., Illescas, O., Lorenc, E., Battistessa, D., Bella, M. D., Zanutto, S., & Gariboldi, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1569337 · Cited by 24
How organ-on-a-chip is advancing cancer research and oncology - a cancer hallmarks’ perspective
Avula, L. R., & Grodzinski, P. A. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1487377 · Cited by 25
“Rijal et al. developed a reconstitutable tissue matrix scaffold (TMS) system which was fabricated using native tissue ECM with structural and compositional features that promote robust cell proliferation, survival, migration, and invasion in culture (Rijal and Li, 2017).”
Bioinks of Natural Biomaterials for Printing Tissues
Rijal, G. (2023) · Bioengineering · doi:10.3390/bioengineering10060705 · Cited by 30
“Recently, dECM-based bioinks have been considered the front-line bioinks for tissue regeneration and tumor models [38,39].”
BackgroundSelf-citationAdvanced tumor organoid bioprinting strategy for oncology research
Cui, X., Jiao, J., Yang, L., Wang, Y., Jiang, W., Yu, T., Li, M., Zhang, H., Chao, B., Wang, Z., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101198 · Cited by 35
“3D models allow for the replication of tumor migration and proliferation in vivo [10], and more accurately reflect tumor responses to anti-tumor drugs [11 – 14].”
BackgroundEngineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research
Jo, H., Lee, S., Kim, M., Park, S., & Lee, S. (2024) · Biosensors · doi:10.3390/bios14110539 · Cited by 27
Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis models
VandenHeuvel, S. N., Farris, H. A., Noltensmeyer, D. A., Roy, S., Donehoo, D. A., Kopetz, S., Haricharan, S., Walsh, A. J., & Raghavan, S. A. (2022) · Soft Matter · doi:10.1039/d1sm01796a · Cited by 20
Sun, Y., Hsu, C., Ling, T., Liu, L., Lin, T.-C., Jakfar, S., Young, I.-C., & Lin, F. (2020) · Biofabrication · doi:10.1088/1758-5090/ab78ee · Cited by 20
Amorim, S., da Costa, D. S., Pashkuleva, I., Reis, C. A., Reis, R. L., & Pires, R. A. (2020) · Biomaterials Science · doi:10.1039/d0bm00843e · Cited by 22
Grocott, T., Lozano-Velasco, E., Mok, G. F., & Münsterberg, A. (2020) · Development · doi:10.1242/dev.185827 · Cited by 31
Reconstruction of tumor microenvironment via in vitro three-dimensional models
Zhou, Z., He, J., Pang, Y., & Sun, W. Y. (2023) · Biofabrication · doi:10.1088/1758-5090/acd1b8 · Cited by 18
Bhattacharya, T., Kumari, M., Kaur, K., Kaity, S., Arumugam, S., Ravichandiran, V., & Roy, S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00680a · Cited by 21
Nanostructured biomaterials for in vitro models of bone metastasis cancer
Katti, K. S., Jasuja, H., Kar, S., & Katti, D. R. (2020) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2020.100254 · Cited by 18
Slivac, I., Zdraveva, E., Ivančić, F., Žunar, B., Grgurić, T. H., Srček, V. G., Svetec, I., Dolenec, T., Bajsić, E. G., Trcin, M. T., et al. (2021) · Polymers · doi:10.3390/polym13020279 · Cited by 18
“Immobilized multilayered cell culture, especially on natural ECMs or hydrogels with collagen, provides a more physiologically relevant system for studying normal and malignant human tissues than monolayer cultures [32].”
BackgroundIdentification of the Collagen Types Essential for Mammalian Breast Acinar Structures
Keller, C. R., Ruud, K. F., Martinez, S. R., & Li, W. (2022) · Gels · doi:10.3390/gels8120837 · Cited by 16
“Matrigel contains mainly laminin and Col IV, with minimal amounts of other collagens [8,10].”
BackgroundMethodSelf-citationde Villiers, M., Kotzé, A. F., & Plessis, D. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad651f · Cited by 17
“Commonly employed methods include agitation-based techniques, which use rotating systems or spin-ner flasks [22–24], 3D matrices [25, 26], micro-fluidic methods such as organ on a chip [27–29], hanging drop techniques [30–32], and external force methods including magnetic, electric, centrifugal, or…”
Advanced Hydrogels in Breast Cancer Therapy
Gao, X., Caruso, B. R., & Li, W. (2024) · Gels · doi:10.3390/gels10070479 · Cited by 18
“Collagens, especially type I collagen, are the most abundant ECM proteins in both normal and cancerous breast tissues [12,58–60].”
BackgroundInfluentialSelf-citationEngineering stromal heterogeneity in cancer
Tang, L. J. W., Zaseela, A., Toh, C. C. M., Adine, C., Aydar, A. O., Iyer, N. G., & Fong, E. L. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.027 · Cited by 16
Matrix mechanophysical factor: pore size governs the cell behavior in cancer
Rahman, M. S. U., Wu, J., Chen, H., Sun, C., Liu, Y., & Xu, S. (2022) · Advances in Physics X · doi:10.1080/23746149.2022.2153624 · Cited by 27
“Tissue matrix scaffold (TMS) system fabricated using native tissue ECM [119] The structural composition of TMS favors robust cell survival, proliferation, migration, and invasion in culture and vascularized tumor formation in animals .”
MethodKumar, V., & Packirisamy, G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124827 · Cited by 15
Wang, X., Yang, X., Liu, Z., Shen, Z., Li, M., Cheng, R., Zhao, L., Xi, Y., Wang, J., & Sang, S. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.07.019 · Cited by 15
Injectable three-dimensional tumor microenvironments to study mechanobiology in ovarian cancer
Horst, E. N., Novak, C. M., Burkhard, K. M., Snyder, C. S., Verma, R., Crochran, D. E., Geza, I. A., Fermanich, W., Mehta, P., Schlautman, D. C., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.039 · Cited by 16
Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
Fernandes, S., Cassani, M., Pagliari, S., Filipenský, P., Cavalieri, F., & Forte, G. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200625151134 · Cited by 15
Rapid fabrication and screening of tailored functional 3D biomaterials
Conde-González, A., Dutta, D., Wallace, R. J., Callanan, A., & Bradley, M. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110489 · Cited by 13
“3D hydrogels and scaffolds have been explored in order to simulate the complexity of native tissues [12,13].”
Future Research Directions in the Design of Versatile Extracellular Matrix in Tissue Engineering
Setiawati, A., Nguyen, H. T., Jung, Y., & Shin, K. (2018) · International Neurourology Journal · doi:10.5213/inj.1836154.077 · Cited by 13
“The advantages of native ECMs lie in their ability to provide the necessary environmental cues to stimulate cell-based repair pathways and to promote adaptive remodeling toward functional recovery [18].”
BackgroundWu, L., Wu, G., Wu, D., Hu, W., Du, Q., Lu, Q., Wang, J., Xie, A., Yang, Y., Liu, J., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503515 · Cited by 17
“The seeding density for HepG2 cells was chosen based on established protocols for biomaterial biocompatibility assessments [24, 51].”
Garakani, M. M., Cooke, M. E., Wertheimer, M. R., Rosenzweig, D. H., & Ajji, A. (2022) · Plasma Processes and Polymers · doi:10.1002/ppap.202100206 · Cited by 15
Three-Dimensional Silk Fibroin/Chitosan Based Microscaffold for Anticancer Drug Screening
Niu, H., Xiao, J., Lou, X., Guo, L., Zhang, Y., Yang, R., Yang, H., Wang, S., & Niu, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.800830 · Cited by 11
Investigating TNS4 in the Colorectal Tumor Microenvironment Using 3D Spheroid Models of Invasion
Raposo, T. P., Susanti, S., & Ilyas, M. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000031 · Cited by 13
Dellaquila, A., Dujardin, C., Bao, C.-L., Chaumeton, C., Carré, A., Guilcher, C. L., Lam, F., & Simón-Yarza, T. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213636 · Cited by 9
Liu, X., Ren, Y., Fu, S., Chen, X., Hu, M.-B., Wang, F., Wang, L., & Li, C. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02575f · Cited by 12
Bhartiya, A., Madi, K., Disney, C., Courtois, L., Jupe, A. C., Zhang, F., Bodey, A. J., Lee, P. D., Rau, C., Robinson, I. K., et al. (2019) · Journal of Synchrotron Radiation · doi:10.1107/s1600577519015583 · Cited by 11
Keller, C. R., Hu, Y., Ruud, K. F., VanDeen, A. E., Martinez, S. R., Kahn, B. T., Zhang, Z., Chen, R. K., & Li, W. (2021) · Cancers · doi:10.3390/cancers13225857 · Cited by 12
“To examine the microstructures of the polymerized HB-TMG associated with certain cellular phenotypes in 3D tissue cultures, we coated the hydrogel on glass slides, polymerized in an incubator at 37 °C (5% CO2), stained with antibody for Col I that is a major structural component of animal and human breast tissue ECM […”
BackgroundMethodInfluentialSelf-citationMatrisome provides a supportive microenvironment for oral squamous cell carcinoma progression
He, Y., Deng, P., Yan, Y., Zhu, L., Chen, H., Li, T., Li, Y., & Li, J. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104454 · Cited by 12
Three-Dimensional Spheroids for Cancer Research
Tutty, M. A., & Prina‐Mello, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3056-3_3 · Cited by 13
Cell Culture and Coculture for Oncological Research in Appropriate Microenvironments
Chhetri, A., Chittiboyina, S., Atrian, F., Bai, Y., Delisi, D., Rahimi, R., Garner, J., Efremov, Y. M., Park, K., Talhouk, R., et al. (2019) · Current Protocols in Chemical Biology · doi:10.1002/cpch.65 · Cited by 11
“There have also been several nonbi-ological gels designed as scaffolds for the culture of tumors (Rijal & Li, 2017).”
Tang, R., Umemori, K., Rabin, J. M., & Alsberg, E. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000156 · Cited by 12
Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer
Ji, K., Zhao, Z., Sameni, M., Moin, K., Xu, Y., Gillies, R. J., Sloane, B. F., & Mattingly, R. R. (2021) · Cancers · doi:10.3390/cancers13236044 · Cited by 11
Metadata
- Authors
- Rijal, G., & Li, W.
- Affiliations
- Washington State University Spokane (US)
- Corresponding author
- Li, Weimin
- Venue
- Science Advances
- Published
- 2017-09
- Volume
- 3
- Issue
- 9
- Pages
- e1700764-e1700764
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC5597314
- OpenAlex
- W2754118249
- Cited by
- 154
- References
- 58
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 22 · 2023: 18 · 2022: 24 · 2021: 27 · 2020: 24 · 2019: 10 · 2018: 8 · 2017: 1
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Washington State University (award329921, Start-up fund)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- tumor modeling, anticancer drug screening, 3D cell culture, extracellular matrix, tumor microenvironment, tumor invasion, hydrogel scaffolds, preclinical drug testing
- MeSH terms
- Animals, Antineoplastic Agents, Cell Survival, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Extracellular Matrix, Humans, Stromal Cells, Coculture Techniques, Hydrogels, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tissue Culture Techniques, Cell Proliferation, Mice, Tissue Scaffolds, Workflow
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.